Skip to main content Help with accessibility Skip to main navigation

DAPAGLIFLOZIN and EMPAGLIFLOZIN for treating chronic kidney disease: a multiple prescribing statement

CCG Approval Status:

Date Added: 28 - Feb - 2024
Body System:

The Cheshire and Merseyside Area Prescribing Group recommends DAPAGLIFLOZIN and EMPAGLIFLOZIN as options for treating chronic kidney disease, in accordance with NICE TA775 and NICE TA942.

NHS Cheshire and Merseyside APPROVED